The page is the record's research on the issuer — no analyst, no rating, no view.

# Astellas Pharma Inc. (Prime Market: 4503) — research page

As of 2026-11-06 · jp-cm-kg · record version 1

## Identity and listing

The issuer is Astellas Pharma Inc., listed on the Prime Market under ticker 4503. Its ISIN is JP3942400007 and its LEI is 529900IB708DY2HBBB35. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.

## The disclosure read

The record holds 12 filings in the window 2025-11-06 to 2026-11-06, across 8 filing days. By type, the record holds 2 ad hoc, 3 prospectus, 4 regulatory filing and 3 results filings. The median gap between filing days is 18 days. The latest filing is dated 2026-11-06, is of type regulatory filing, and is 0 days before the record date of 2026-11-06. The Prime Market median is 10 filings, a cadence gap of 29.0 days and a latency of 70.0 days across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a cadence gap of 49.5 days and a latency of 85.0 days across 80 issuers.

## Auditor

The auditor of record is EY新日本有限責任監査法人. Its location is not on the record. The record does not carry auditor changes.

## Events and halts

The record does not carry listing, delisting, name change, domicile change or segment move lines, as the index has no lifecycle type map for this register. The halt flag shows listed, not halted.

## Orderability

For the client category Qualified Institutional Investors, the outcome is not determinable and the signal is null. The reason given is that the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

## Coverage

The issuer's own investor-relations page names 15 research houses: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; Daiwa Securities Co. Ltd.; Goldman Sachs Japan Co., Ltd.; Jefferies Japan Limited; JPMorgan Securities Japan Co., Ltd.; Macquarie Capital Securities (Japan) Limited; Mizuho Securities Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; Nomura Securities Co., Ltd.; Sanford C. Bernstein Japan KK; SMBC Nikko Securities Inc.; UBS AG; SBI Securities Co.,Ltd.; and CLSA.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.

## Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4503 (the disclosure lines)
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YBPK (the auditor)
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.astellas.com/en/investors/stock-and-analyst-information (coverage)
- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4503 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-PRIME/4503 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
